Skip to content

The efficacy of multiparameter functional magnetic resonance imaging in noninvasive assessment of clinicopathological changes and prediction of renal function progression in patients with chronic kidney disease

The efficacy of multiparameter functional magnetic resonance imaging in noninvasive assessment of clinicopathological changes and prediction of renal function progression in patients with chronic kidney disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092363
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Index test:3.0T multi-parameter functional magnetic resonance imaging technology, including DWI, DTI, IVIM, BOLD, T1 mapping, ASL, etc.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Population with high risk factors of CKD, suspected CKD and planned to undergo renal biopsy, such as proteinuria, hematuria, increased serum creatinine level, decreased eGFR, abnormal renal color Doppler ultrasound; 2. The control group was healthy volunteers without any kidney disease, with or without other system diseases. If there were other system diseases, it would not affect the structure and function of the kidney; This includes the following: (1) No history of hypertension, diabetes and other basic diseases; (2) No history of hydronephrosis, nephrolithiasis or nephritis; (3) normal urine routine and renal function in recent half a year; (4) no recent use of nephrotoxic drugs; (5) can cooperate with the end of breath hold; (6) There was no contraindication of magnetic resonance examination, and the conventional T1 and T2 weighted magnetic resonance imaging scan showed normal renal morphology.

Exclusion criteria

Exclusion criteria: 1. Population with concomitant diseases that may affect the morphology or structure of the kidney, such as renal tumor, hydronephrosis, urinary tract infection, polycystic kidney, and other abdominal lesions, such as chronic pancreatitis and retroperitoneal fibrosis; 2. There were contraindications to MRI examination, such as metal implants in the body or failure to cooperate with breath holding.

Design outcomes

Primary

MeasureTime frame
Group differences of fMRI indicators;Correlation between fMRI indicators and clinicopathological indicators;Diagnostic efficacy of fMRI indicators (sensitivity, specificity);Efficacy of fMRI indicators in predicting renal function progression;

Countries

China

Contacts

Public ContactQin Wei

West China Hospital, Sichuan University

qinweihx@scu.edu.cn+86 189 8060 2119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026